FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304695595> ?p ?o ?g. }

• W4304695595 endingPage "e064216" @default.
• W4304695595 startingPage "e064216" @default.
• W4304695595 abstract "Rituximab (RTX) effectively prevents relapses in patients with complicated steroid-sensitive nephrotic syndrome (SSNS). The 1-year relapse-free survival rate is approximately 30% in children after the first episode of SSNS treated with standardised corticosteroids. Whether the benefits of RTX extend to the first relapse are unknown. The efficacy and safety of RTX in the first episode of paediatric idiopathic nephrotic syndrome (RTXFIRPedINS) trial (NCT04783675) will assess its effect on the risk of subsequent relapse.RTXFIRPedINS is an open-label, single-arm, multicentre trial targeting patients aged 1-18 years with a first episode of SSNS. All patients will receive standardised corticosteroid treatment for 12 weeks. A sample size of 44 patients provides 80% power to detect a 20% increase in the 1-year relapse-free rate, assuming a dropout rate of 10%. After obtaining informed consent and screening, eligible patients will be treated with a single intravenous infusion of 375 mg/m2 RTX within 1 week after achieving remission. Trimethoprim-sulfamethoxazole will be administered for 3 months after RTX administration to prevent Pneumocystis carinii infection. The follow-up period will be 1 year. The primary outcome is the 1-year relapse-free survival rate after RTX infusion. The secondary study outcomes are the number of days from the infusion of RTX to the occurrence of the first relapse, 6-month relapse-free survival rate, the B cell recovery time and treatment-related adverse events. Immunological factors will be studied as predictors of response.This trial was approved by the Ethics Committee of the Children's Hospital of Fudan University and seven local ethics committees. We will publish our study results in peer-reviewed journals and present them at international scientific meetings.NCT04783675." @default.
• W4304695595 created "2022-10-12" @default.
• W4304695595 creator A5011888335 @default.
• W4304695595 creator A5029817092 @default.
• W4304695595 creator A5033955006 @default.
• W4304695595 creator A5034854007 @default.
• W4304695595 creator A5037677450 @default.
• W4304695595 creator A5041502445 @default.
• W4304695595 creator A5048379858 @default.
• W4304695595 creator A5087787378 @default.
• W4304695595 creator A5088997186 @default.
• W4304695595 creator A5090859164 @default.
• W4304695595 date "2022-10-01" @default.
• W4304695595 modified "2023-10-11" @default.
• W4304695595 title "Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome" @default.
• W4304695595 cites W1569224520 @default.
• W4304695595 cites W2475409549 @default.
• W4304695595 cites W2735768344 @default.
• W4304695595 cites W2808503484 @default.
• W4304695595 cites W3021746826 @default.
• W4304695595 cites W3095408403 @default.
• W4304695595 cites W3141977208 @default.
• W4304695595 cites W3167169072 @default.
• W4304695595 cites W3173680376 @default.
• W4304695595 cites W3176437857 @default.
• W4304695595 cites W3200479416 @default.
• W4304695595 cites W4210537826 @default.
• W4304695595 cites W4211122976 @default.
• W4304695595 cites W4211216661 @default.
• W4304695595 doi "https://doi.org/10.1136/bmjopen-2022-064216" @default.
• W4304695595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36223961" @default.
• W4304695595 hasPublicationYear "2022" @default.
• W4304695595 type Work @default.
• W4304695595 citedByCount "0" @default.
• W4304695595 crossrefType "journal-article" @default.
• W4304695595 hasAuthorship W4304695595A5011888335 @default.
• W4304695595 hasAuthorship W4304695595A5029817092 @default.
• W4304695595 hasAuthorship W4304695595A5033955006 @default.
• W4304695595 hasAuthorship W4304695595A5034854007 @default.
• W4304695595 hasAuthorship W4304695595A5037677450 @default.
• W4304695595 hasAuthorship W4304695595A5041502445 @default.
• W4304695595 hasAuthorship W4304695595A5048379858 @default.
• W4304695595 hasAuthorship W4304695595A5087787378 @default.
• W4304695595 hasAuthorship W4304695595A5088997186 @default.
• W4304695595 hasAuthorship W4304695595A5090859164 @default.
• W4304695595 hasBestOaLocation W43046955951 @default.
• W4304695595 hasConcept C126322002 @default.
• W4304695595 hasConcept C187212893 @default.
• W4304695595 hasConcept C197934379 @default.
• W4304695595 hasConcept C2778930706 @default.
• W4304695595 hasConcept C2779338263 @default.
• W4304695595 hasConcept C2780653079 @default.
• W4304695595 hasConcept C535046627 @default.
• W4304695595 hasConcept C71924100 @default.
• W4304695595 hasConceptScore W4304695595C126322002 @default.
• W4304695595 hasConceptScore W4304695595C187212893 @default.
• W4304695595 hasConceptScore W4304695595C197934379 @default.
• W4304695595 hasConceptScore W4304695595C2778930706 @default.
• W4304695595 hasConceptScore W4304695595C2779338263 @default.
• W4304695595 hasConceptScore W4304695595C2780653079 @default.
• W4304695595 hasConceptScore W4304695595C535046627 @default.
• W4304695595 hasConceptScore W4304695595C71924100 @default.
• W4304695595 hasIssue "10" @default.
• W4304695595 hasLocation W43046955951 @default.
• W4304695595 hasLocation W43046955952 @default.
• W4304695595 hasLocation W43046955953 @default.
• W4304695595 hasOpenAccess W4304695595 @default.
• W4304695595 hasPrimaryLocation W43046955951 @default.
• W4304695595 hasRelatedWork W1487881706 @default.
• W4304695595 hasRelatedWork W1550877063 @default.
• W4304695595 hasRelatedWork W2067778425 @default.
• W4304695595 hasRelatedWork W2124380845 @default.
• W4304695595 hasRelatedWork W2143803333 @default.
• W4304695595 hasRelatedWork W2402835770 @default.
• W4304695595 hasRelatedWork W2571795535 @default.
• W4304695595 hasRelatedWork W3029812694 @default.
• W4304695595 hasRelatedWork W3128082782 @default.
• W4304695595 hasRelatedWork W2517178969 @default.
• W4304695595 hasVolume "12" @default.
• W4304695595 isParatext "false" @default.
• W4304695595 isRetracted "false" @default.
• W4304695595 workType "article" @default.